Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry — Kamilla Steensig (2018) | RDL Network
Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry
Article 2018 en
Authors
KS
Kamilla Steensig
KO
Kevin Kris Warnakula Olesen
TT
Troels Thim
Abstract
1 min read
Presence, but not extent, of CAD was an independent risk factor of the composite thromboembolic endpoint beyond the components already included in the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. Consequently, we suggest that significant angiographically proven CAD should be included in the vascular disease criterion in the CHA<sub>2</sub>DS<sub>2</sub>-VASc score.
Moonki Jung, Kyeongmin Byeon, Ki‐Woon Kang, Yae Min Park, You Mi Hwang, Sung Ho Lee, Eun‐Sun Jin, Seung‐Young Roh, Jin Seok Kim, Jinhee Ahn, So-Ryoung Lee, Eue-Keun Choi, Min‐Soo Ahn, Eun Mi Lee, Hwan-Cheol Park, Ki Hong Lee, Min Kim, Joon‐Hyouk Choi, Jum Suk Ko, Jin‐Bae Kim, Changsoo Kim, Professor Gregory Lip, Seung Yong Shin
Discussion(0)
No comments yet. Be the first to comment.